Organigram Global (OGI) Cash & Equivalents (2023 - 2025)

Organigram Global has reported Cash & Equivalents over the past 3 years, most recently at $60.7 million for Q3 2025.

  • Quarterly Cash & Equivalents fell 37.51% to $60.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $60.7 million through Sep 2025, down 37.51% year-over-year, with the annual reading at $59.8 million for FY2025, 38.47% down from the prior year.
  • Cash & Equivalents was $60.7 million for Q3 2025 at Organigram Global, down from $97.2 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $97.2 million in Q3 2024 and troughed at $38.6 million in Q3 2023.
  • The 3-year median for Cash & Equivalents is $60.7 million (2025), against an average of $65.5 million.
  • Year-over-year, Cash & Equivalents surged 151.78% in 2024 and then crashed 37.51% in 2025.
  • A 3-year view of Cash & Equivalents shows it stood at $38.6 million in 2023, then surged by 151.78% to $97.2 million in 2024, then tumbled by 37.51% to $60.7 million in 2025.
  • Per Business Quant, the three most recent readings for OGI's Cash & Equivalents are $60.7 million (Q3 2025), $97.2 million (Q3 2024), and $38.6 million (Q3 2023).